Destiny Wealth Partners’s Edwards Lifesciences EW Stock Holding History

Destiny Wealth Partners’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$31.6K	Buy	+394	New	+$32.5K	﹤0.01%	536
2023 Q1	–	Sell	-174	Closed	-$13K	–	324
2022 Q4	$13K	Buy	174 +10	+6%	+$771	﹤0.01%	448
2022 Q3	$14K	Hold	164	–	–	﹤0.01%	393
2022 Q2	$16K	Buy	+164	New	+$17K	﹤0.01%	382
2021 Q2	–	Sell	-63	Closed	-$5K	–	285
2021 Q1	$5K	Hold	63	–	–	﹤0.01%	453
2020 Q4	$6K	Buy	+63	New	+$5.23K	﹤0.01%	442

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Destiny Wealth Partners's EW Position: Q1 2026 in Review

Destiny Wealth Partners opened a new position in Edwards Lifesciences (EW) in Q1 2026: 394 shares worth $31.6K. The stake represents ﹤0.01% of the portfolio and ranks #536 among its holdings. This is a return to the name: Destiny Wealth Partners previously reported a position in EW as recently as Q4 2022.

Destiny Wealth Partners first reported a position in EW in Q4 2020 and has held it in 6 quarters since. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Destiny Wealth Partners held 394 shares of Edwards Lifesciences worth $31.6K as of Q1 2026.
Edwards Lifesciences was a new Destiny Wealth Partners position in Q1 2026.
Edwards Lifesciences made up ﹤0.01% of Destiny Wealth Partners's portfolio in Q1 2026, its #536 holding.
Destiny Wealth Partners first reported a position in Edwards Lifesciences in Q4 2020 and has held it in 6 quarters since.
1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Destiny Wealth Partners's 13F filing for Q1 2026, filed 11 May 2026.